Testing a new wearable sensor for glucose and ketone monitoring
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study is testing a new wearable sensor that tracks both glucose (sugar) and ketone levels continuously. It might help people with type 1 diabetes manage their condition better and avoid complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with type 1 diabetes for at least 1 year and still need insulin to manage it.
- You must currently be using an insulin pump to deliver your insulin.
- You must agree to follow the study plan and sign a consent form.
- You must be willing to let the study team access your medical records.
- You must be able to read and write in the study's language (likely English).
- You cannot have had any severe low blood sugar or diabetic ketoacidosis in the past 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This trial tests a new device that measures blood sugar and ketones continuously. It may help people with type 1 diabetes who use an insulin pump keep better track of their levels.
This study tests a new wearable sensor to see if it can help people with type 1 diabetes better track their blood sugar levels. It might lead to easier and more accurate glucose monitoring.
This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.
This study tests different ways to monitor ketones (substances that can build up dangerously when your body lacks insulin) to lower the risk of diabetic ketoacidosis (DKA) in people with type 1 diabetes who also take SGLT-2 inhibitors (a type of diabetes drug). You'll wear a small sensor and follow a meal plan with carbs.
This study tests a wearable device that may measure blood sugar without needles. It could help people manage their diet and health more easily.
Hear when a new Type 1 Diabetes (T1D) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.